How the Brain's Endocannabinoid System Fine-Tunes Inhibitory Signaling | Research

The takeaway

Researchers identified multiple interacting mechanisms by which the endocannabinoid system controls GABA release in the hippocampus, including constitutively active CB1 receptors and opposing 2-AG and anandamide signaling pathways.

Read this if you are interested in the neuroscience of how cannabis affects brain signaling at the molecular level.

CB1 receptors are constitutively active, continuously suppressing GABA release

What the researchers found

Using advanced electrophysiology and imaging in mouse hippocampus, researchers discovered that CB1 receptors at inhibitory synapses are constitutively active, meaning they continuously suppress GABA release even without being activated by endocannabinoids.

The endocannabinoid 2-AG is continuously produced and further suppresses GABA release, but its effect is tightly controlled by the presynaptic enzyme MGL. Surprisingly, anandamide acts through TRPV1 receptors to oppose 2-AG signaling, creating a push-pull regulatory mechanism.

These effects were specific to perisomatic (cell body-targeting) synapses and did not occur at dendritic synapses, revealing synapse-specific endocannabinoid regulation.

Why it matters

This study reveals that the endocannabinoid system does not simply turn inhibition on or off but uses multiple interacting molecular mechanisms to precisely calibrate how much GABA different synapses release. This complexity has implications for understanding how cannabis disrupts these finely tuned circuits.

The numbers in context

CB1 inverse agonist AM251 increased transmission; neutral antagonist NESS0327 did not; JZL184 (MGL inhibitor) increased 2-AG and decreased GABA transmission; PF3845 (FAAH inhibitor) elevated anandamide but did not change synaptic activity directly

How the study worked

Combined paired whole-cell patch-clamp recordings, liquid chromatography/tandem mass spectrometry for endocannabinoid measurement, super-resolution microscopy (STORM), and immunogold electron microscopy in mouse hippocampus.

What this study cannot tell us

Animal study using mouse hippocampal slices. In vitro conditions may not fully replicate in vivo dynamics. Translation to human brain function requires caution. Focused on one brain region.

How to read the evidence

Rigorous animal study with cutting-edge methodology, but findings are from mouse brain slices and require human validation.

When this study was published

Published in 2015. Endocannabinoid neuroscience has continued to advance.

The bigger picture

The discovery that anandamide and 2-AG have opposing effects at the same synapses through different receptor systems adds a new layer of complexity to endocannabinoid signaling. Cannabis use floods this delicate system with external THC, potentially disrupting the fine-tuned balance.

Questions still open

How does chronic cannabis exposure affect this push-pull regulatory mechanism? Do similar synapse-specific endocannabinoid regulations exist in other brain regions? Could targeting these specific pathways lead to more precise therapeutic interventions?

Common questions

What does this mean for cannabis users?

The brain uses a delicate balance of endocannabinoid signals to control inhibitory neurotransmission. THC from cannabis mimics 2-AG at CB1 receptors, potentially overwhelming this finely tuned system and disrupting the balance between excitation and inhibition.

What is the difference between 2-AG and anandamide?

Both are endocannabinoids made naturally in the brain. This study found they have opposing effects at certain synapses: 2-AG suppresses GABA release through CB1 receptors, while anandamide counteracts this through TRPV1 receptors, creating a regulatory balance.

Read the original research

Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 35(27), 10039-57

View on PubMed ↗Publisher’s paper ↗

Citation

Lee, Sang-Hun; Ledri, Marco; Tóth, Blanka; Marchionni, Ivan; Henstridge, Christopher M; Dudok, Barna; Kenesei, Kata; Barna, László; Szabó, Szilárd I; Renkecz, Tibor; Oberoi, Michelle; Watanabe, Masahiko; Limoli, Charles L; Horvai, George; Soltesz, Ivan; Katona, István. (2015). Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 35(27), 10039-57. https://doi.org/10.1523/JNEUROSCI.4112-14.2015